The Sage Group
WHO WE ARE
​
The Sage Group is an organization of experienced and successful executives who are committed to the service of the healthcare industry and its stakeholders. We are based in USA, Europe, China, Japan, India, Middle East and Asia.
For 30 years, Sage Group has been a leader in the provision of strategic and transactional advice to healthcare and life science companies in the diagnostics, medical device, pharmaceutical, biotechnology and bioscience fields. We transform ideas, strategy and technology into shareholder value. We turn ambitions into results and achievement of success.
​
We create your value through our network!
We have operated globally with considerable deal flow and achieved extensive commercial success for our clients.
OUR SERVICES
We provide a range of highly focused services for our global clients in healthcare and life sciences including:
​
-
Buyside and Sellside Licensing for Products and Technologies
-
Mergers, Aquisitions, Asset and IP Divestments
-
Aquisition Searches and Buy to Build
-
Business Development, Corporate Partnering
-
Through affiliates, we offer pricing and market access assessments in the US and Europe
-
Through affiliates, we offer regulatory advice and guidance in the US, Europe and APAC
-
Value Modelling
SECTORS OF EXPERTISE
Our clients are our most important assets. Sage corporate clients include Pharmaceutical and Biotechnology Companies in virtually every sector of healthcare:
-
Cardiology and Cardio-Metabolic
-
Dermatology
-
Endocrinology
-
Hematology
-
Immunology
-
Infectious Diseases
-
Metabolic Diseases
-
Nephrology and Hepatology
-
Neurology, CNS and Mental Health
-
Oncology
-
Ophthalmology
-
Pediatric Diseases
-
Rare Disease
-
Respiratory Diseases
-
Urology
-
Virology
-
Women's Healthcare
Involving the following technologies
-
AI
-
Cell therapy
-
Gene therapy
-
Immunology and Molecular Biology
-
Regenerative medicine
-
Drug Delivery
-
Drug Discovery
-
In-vitro Diagnostics and Laboratory Service
-
Medical Devices
In addition, we work closely with Venture Capital and Private Equity Investors, Financial Institutions and Banks